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Advanced computational tools to enhance 
continuous monoclonal antibody production 
The System 
• GS-NS0 cell culture system 
• 5 Key compounds: 
 Glucose 
 Glutamate 
 Arginine 
 Asparagine 
 Aspartate 
PAROC Framework and Software Platform 
• 25 Differential and 
Algebraic Equations. 
• 26 Differential and 
Algebraic Variables. 
• 25 Parameters. 
High-fidelity Dynamic Modeling 
System Identification & Multi-parametric 
Programming Problem 
   
• 2 states 
• 2 hours  sampling time 
• ~95% fit on the process 
model 
‘Closed-loop’ Validation 
• Output Horizon: 2 
• Control Horizon: 2 
• 4 Parameters 
Figure 1. Comparison of simulation results and experimental data for the GS-
NS0 Batch Cultures: (a) Concentration of viable cells (Cells/L): (▲) 
Experimental Results (---) Predictive Model Results. (b) mAb concentration 
(mg/L): (●) Experimental Results (---)Predictive Model Results. The 
experimental data used here are obtained from Kiparissides et al. (2015). 
Figure 2 Comparison between the process model output (simulation 
output, ─) and the designed state space model (state space model 
output, - - -). 
Figure 3 Two-dimensional projection of the critical region polyhedral 
corresponding to the six state space model. 
Figure 4 Results from the in-silico, ‘closed-loop’ validation of the controller for 168 hours culture time: (a) profile of the flow rate (L/hr) 
(input) as indicated by the controller and comparison of the system performance under the operation of the controller (─) and without 
controller (- - -)_ for: (b) concentration of viable cells (mg/mL), (c) accumulation of mAb (mg) and (d) mAb concentration (mg/L). 
• Increased culture productivity. 
• Prolonged culture times. 
• Increased cell density. 
• Smart control input – biological significance. 
Kiparissides, A., Pistikopoulos, E. N. & Mantalaris, A. 2015. On the model-based 
optimization of secreting mammalian cell (GS-NS0) cultures. Biotechnology and 
Bioengineering, 112, 536-548. 
Pistikopoulos, E. N., Diangelakis, N. A., Oberdieck, R., Papathanasiou, M. M., Nascu, I. 
& Sun, M. 2015. PAROC—An integrated framework and software platform for the 
optimisation and advanced model-based control of process systems. Chemical 
Engineering Science, 136, 115-138. 
• Model-based controller 
development. 
• Seamless, in-silico 
validation. 
• Software 
interoperability 
• Map of solutions on 
small, embedded 
devices 
(MPC-on-a-chip). 
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